Oh dear. Oh dearie me. With the share price of embattled AIM-listed CloudTag (CTAG) still coming down faster than a Waseem Shakoor post on the LSE CTAG BB, the bid price has dropped to just 5.25p last seen. If my maths is right, L1’s outstanding loan notes can’t all be converted until after the forthcoming EGM (assuming that shareholders approve the relevant resolutions). Even then, it looks as though Tranche 2 is in danger of not being convertible if the bid price falls much further. Perhaps the Nomad, Cairn Financial, might wish to have the matter clarified to the market.

Last year my three part Christmas Carol series starred white collar criminal Chris Oil. The year before it was fraudster Rob Terry. But who to go for this year? There are so many choices. I have a few ideas on my short list below but what do you think?

I sense that Waseem and I will not be getting that many Christmas cards this year from the morons who still hold shares in Cloudtag (CTAG) but we did warn you time and time again. Waseem has now issued another stark warning: If you think the share price meltdown is going to reverse, think again. It is about to accelerate! The great man writes:

An easing of debt risk for Petropavlovsk (POG) has moved a significant step closer – with it announced that the company has received approvals for the refinancing of its entire bank debt of $529.8 million from its lending banks, Sberbank and VTB.

Yesterday Cloudtag (CTAG) finally fessed up that Corvus Capital, the vehicle of dodgy Andrew Regan had dumped all its shares months ago at the peak of the ramp onto unsuspecting Bulletin Board Morons. But there was another belated disclosure of share dumping by Michael Hirschfield, as Nigel noted HERE. Mike who you say? Oooh er missus.

Amryt Pharma (AMYT) has announced that it has secured a €20m debt facility from the European Investment Bank on, what broker Stifel says, are very attractive commercial terms. Stifel says that the facility will not only extend the company's funding until well into 2019, but also provide funding for development of acromegaly product AP102 and potential launch funding for Episalvan in partial thickness wounds. Stifel concludes that the shares are a buy at 14p with a price target of 49p. Yes indeed. Since we own the shares I thought we'd share the note with you.

Hulsey Smith was the chap whose Court filings demonstrated wholesale fraud at Strat Aero (AERO) - filings we published HERE despite Aero's legal attempts to hush them up. So when he settled his claims with a cash and shares payoff - weeks after Strat promised to fight him all the way - you kind of knew he'd dump sooner or later. Why hold shares in a company that commits fraud?

Reviewing results for the six months ended 30th September 2016 from Digital Barriers (DGB), I noted a £7.4 million reduction in net cash to £3.4 million and that the company has established a £10 million revolving credit facility. It has now made a “Contract wins across APAC and EMEA” announcement. Hmmm…

Hello Share Bashers. Selling computers and phones and big screen television sets has not been easy. In recent years, quite a few stores have disappeared from our high streets and out of town shopping centres.

Oh dear, oh dear. Those Worthington (WRN) shareholders who were dreaming of buying a mansion in Monaco with their golden tickets might wish to brace themselves for bad news. as you can see below the First Gazette notice for striking off has been published and an administrator appointed. On the terraces at Banstead Athletic the chant is already starting "you're going down with Golden Saint, you're going down with Golden Saint" Nuff said.

She was horrified. I am not sure she agreed with my line that the mainstream press were part of the problem not the solution but she agreed that AIM had its issues. On the bearcast today I look at Red Leopard (RLH), Formation Group (FRM), Mobile Streams (MOS) and its charming CEO - Andalas (ADL) - whose CEO is a tosser - Strat Aero (AERO), Finnaust (FAM), Inspirit (INSP), Plus 500 (PLUS), Advanced Oncotherapy (AVO)), TrakM8 (TRAK) and Cloudtag (CTAG) plus one way of looking at it which sees 300 companies on AIM as a sort of fraud.

Oh dear oh dear. First of all we get the ‘fessing up RNS from AIM-listed CloudTag (CTAG) that Corvus Capital sold out more than two years ago but the market was not told until today. Then another overdue notification hits the wire. Tut tut.

In the face of relentless pressure from this website, embattled Advanced Oncotherapy (AVO) yesterday put out a statement attempting to draw a line in the sand over its falling out with Sinophi, whom it had claimed was set to buy $120 million of machines from it. It has failed. the statement begs even more questions and the shares remain utterly uninvestable.

I am back in the Hellenic Republic once again and it appears that there may be a few problems ahead for AIM listed Plus 500 (PLUS) in the Greek speaking world. A contact flags up developments in Cyprus where - as you can see in the attached document - Plus does much of its business.

The company with the exclusive right to develop, operate and sub-franchise Domino's Pizza stores in Poland, DP Poland (DPP) has announced the sale and sub-franchising of 4 stores in Krakow – and the shares have reacted further higher…

I bloody well told you all that that Corvus Capital, the vehicle of uber-dodgy Andrew Regan had dumped all its shares in Cloudtag (CTAG) onto bulletin board morons ages ago. Natch the morons denied it all, insisting that the "visionary" Regan was still on board. Uh oh...Cloudtag has fessed up. Another small victory for the Sheriff of AIM.

Eleven days ago I updated the death list portfolio which now sees me on ten kills from 31. However I now take Wandisco (WAND) off the death list after the recent management change. We need a replacement so entrant number 32 is ...IGAS. It looks as we may need two new entrants soon given the recent news from Worthington (WRN) and the FRAUD African Potash (AFPO) but that can wait for another day.

2016 has been the most peculiar year for gold that I can remember. On the surface, 2016 has been a typical year with a gain year-to-date of 11 pct in dollar terms (31 pct in GBP terms) which is a just shade lower than its annual average gain since 2001 at 12.8 pct. What makes the past year so unusual has been the powerful reversals in buying and indeed selling behaviour from otherwise reliable sectors ... and, this is key ... not all buying is equal and it therefore explains the recent price action and the outlook. I'll explain.

We Optibiotix (OPTI) shareholders have been feeling a bit under the cosh of late as the shares weakened on a lack of news. It was just ennui among those of an impatient disposition but still it was annoying. This week's trading statement should reassure the doubters.

Finally the joke AIM company that is Mosman Oil & Gas (MSMN) has got around to posting notice of its forthcoming General Meeting at where there is just one motion - the re-election of Technical Director and the face of Mosman, Andy Carroll, to the board. This is our chance - we urge you all to vote Carroll of the board.